Within the frontline pharmaceutical pack, I am positive on Lupin and Sun Pharmaceutical Industries, said Dilip Bhat Joint Managing Director, Prabhudas Lilladher.

Speaking to CNBC-TV18, Bhat said, he would still prefer to wait and watch on Dr Reddy's Laboratories. The company still have to spend some time to meet the US Food and Drug Administration (USFDA) regulations and maybe some approvals here and can give them some boost to their overall topline.

According to Bhat, State Bank of India (SBI), country's largest bank, is struggling to breakout.

"We saw some time back, SBI was at a very good level and then it surrendered all its gains. So, I don't think that it will go up in a hurry but SBI will still continue to move sideways, maybe some small uptick here are there," he added.

However, Bhat said there will not be any great upmove on SBI and most of public sector banks and with some extent, even with ICICI Bank and Axis Bank.

Disclaimer:

The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

First Published:Jun 22, 2018 4:58 PM IST